These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25093868)

  • 1. Pilot quasi-randomized controlled study of herbal medicine Hochuekkito as an adjunct to conventional treatment for progressed pulmonary Mycobacterium avium complex disease.
    Enomoto Y; Hagiwara E; Komatsu S; Nishihira R; Baba T; Kitamura H; Sekine A; Nakazawa A; Ogura T
    PLoS One; 2014; 9(8):e104411. PubMed ID: 25093868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ; Wu TS; Chiang PC; Lee MH
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and early outcomes of patients newly diagnosed with pulmonary Mycobacterium avium complex disease.
    Hagiwara E; Katano T; Isomoto K; Otoshi R; Yamakawa H; Okuda R; Sekine A; Baba T; Komatsu S; Ogura T
    Respir Investig; 2019 Jan; 57(1):54-59. PubMed ID: 30366835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbating factors in elderly patients with
    Kodaka N; Nakano C; Oshio T; Watanabe K; Niitsuma K; Imaizumi C; Shimada N; Morita H; Matsuse H
    Epidemiol Infect; 2021 Apr; 149():e117. PubMed ID: 33902774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
    Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibility to rifabutin and novel fluoroquinolones in Mycobacterium avium complex isolates from patients with sputum culture-positive pulmonary disease who are undergoing standard chemotherapy].
    Tateishi Y; Motone M; Yoshimura K; Miki M; Miki K; Kitada S; Hashimoto H; Hiraga T; Maekura R
    Nihon Kokyuki Gakkai Zasshi; 2010 Nov; 48(11):797-802. PubMed ID: 21141056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of environmental exposure on the response to antimicrobial treatment in pulmonary Mycobacterial avium complex disease.
    Ito Y; Hirai T; Fujita K; Kubo T; Maekawa K; Ichiyama S; Togashi K; Mishima M
    BMC Infect Dis; 2014 Sep; 14():522. PubMed ID: 25266993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of pulmonary Mycobacterium avium-intracellulare complex (MAC) infection in comparison with those of tuberculosis.
    Watanabe K; Fujimura M; Kasahara K; Yasui M; Myou S; Watanabe A; Nakao S
    Respir Med; 2003 Jun; 97(6):654-9. PubMed ID: 12814150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
    Kobashi Y; Oka M
    Kekkaku; 2008 Dec; 83(12):779-84. PubMed ID: 19172823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the use of 5-mycoloyl-beta-arabinofuranosyl-(1-->2)-5-mycoloyl- alpha-arabinofuranosyl-(1-->1')-glycerol in serodiagnosis of Mycobacterium avium-intracellulare complex infection.
    Honda I; Kawajiri K; Watanabe M; Toida I; Kawamata K; Minnikin DE
    Res Microbiol; 1993; 144(3):229-35. PubMed ID: 8210680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease.
    Wallace RJ; Brown BA; Griffith DE; Girard WM; Murphy DT; Onyi GO; Steingrube VA; Mazurek GH
    Am J Respir Crit Care Med; 1994 May; 149(5):1335-41. PubMed ID: 8173775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic pitfall: Mycobacterium avium complex pulmonary infection and positive ANCA.
    Faruqi S; Kastelik JA; McGivern DV
    Eur J Intern Med; 2008 May; 19(3):216-8. PubMed ID: 18395168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lichen scrofulosorum caused by pulmonary Mycobacterium avium complex (MAC) infection.
    Tobita R; Sumikawa Y; Imaoka K; Murata S; Dekio I; Maruyama R; Morita E
    Eur J Dermatol; 2011; 21(4):619-20. PubMed ID: 21616750
    [No Abstract]   [Full Text] [Related]  

  • 15. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y; Tsuyuguchi K; Kobayashi T; Kurahara Y; Yoshida S; Kagawa T; Hayashi S; Suzuki K
    J Infect Chemother; 2020 Jul; 26(7):676-680. PubMed ID: 32171660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
    BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease.
    Kobashi Y; Matsushima T; Oka M
    Respir Med; 2007 Jan; 101(1):130-8. PubMed ID: 16750618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
    Lam PK; Griffith DE; Aksamit TR; Ruoss SJ; Garay SM; Daley CL; Catanzaro A
    Am J Respir Crit Care Med; 2006 Jun; 173(11):1283-9. PubMed ID: 16514112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
    Kwon BS; Lee JH; Koh Y; Kim WS; Song JW; Oh YM; Lee SD; Lee SW; Lee JS; Lim CM; Choi CM; Huh JW; Hong SB; Shim TS; Jo KW
    Respir Med; 2019 Apr; 150():45-50. PubMed ID: 30961950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic
    Nakagawa T; Hashimoto H; Yagi M; Kogure Y; Sekimizu M; Saito AM; Ogawa K; Inoue Y
    BMJ Open Respir Res; 2019; 6(1):e000434. PubMed ID: 31258920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.